Extramural Funding
Overall, NCI obligations for its extramural program, which includes grants and contracts, totaled $5.14 billion in FY 2022.
- Obligations for grants totaled approximately 83.1% of extramural funding
- Obligations for contracts totaled approximately 16.9% of extramural funding
Obligations on this page include FY 2022 Cancer Moonshot funding and excludes fiscal years 2017 through 2021 Cures Moonshot carryover obligations.
| Mechanism | Amount | Percent |
|---|---|---|
|
Research & Development (R&D) Contracts |
$835,802,931 |
16.3% |
| Buildings and Facilities | 30,000,000 | 0.6% |
| Construction Contracts | 0 | 0.0% |
| Subtotal Contracts |
$865,802,931 |
16.9% |
| Research Project Grants (RPGs) |
2,966,485,752 |
57.8% |
|
Cancer Centers/Specialized Centers/SPORES |
587,038,951 |
11.4% |
| NRSA |
91,108,610 |
1.8% |
| Other Research Grants |
624,759,676 |
12.2% |
| Subtotal Grants |
$4,269,392,989 |
83.1% |
| Total Extramural Funds | $5,135,195,920 | 100.0% |
| Intramural/RMS Funds |
1,698,407,783 |
|
| Total NCI |
$6,833,603,703 |
|